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Dear Editor,
We thank colleagues Dr. Cravo, Dr. Pazarli, and Dr. Esquinas
for their interest in our study and their comments. First, we
agree that polygraphy has lower sensit ivity than
polysomnography (PSG) especially in cases with a lower re-
spiratory event index (REI) [1]. The mean REI in our study
was 41; therefore, we do not believe that cases of false nega-
tive OSAwere included in our study population. Second, none
of the patients included in the study had obesity
hypoventilation syndrome and, thus, we focused on CPAP
treatment [3]. Third, we have discussed in our paper that the
retrospective study design is one of the study limitations and,
indeed, includes the possibility of recall bias [2]. Finally, the
medication of the patients was analyzed by self-reported use
of rescue medication which is one the questions included in
the asthma control test (ACT). However, as we have discussed
in our paper, further analyses of asthmamedicationwould also
include the possibility of bias since use of medication is re-
ported by patients.
Using information in medical records is a commonly
employed technique in clinical studies. Unfortunately, patients
often use their drugs (both tablets and inhalers) in a different
way than they are prescribed and, thus, even medical record
information on prescribed drugs is only an estimation [4].
Considering the concept of different phenotypes of asthma
and results from other studies on CPAP treatment, we find it
likely that CPAP is mostly beneficial for patients with both
OSA and asthma.
We believe that the benefit of CPAP on asthma is
related to its effect on improving the acinar ventilation
heterogeneity as well as reducing reflux. However, an
important effect involves abolishing respiratory distur-
bances since we found similar results with the use of
mandibular advancement devices [5]. A prospective
study including sleep apnea patients, asthma patients,
and patients with both disorders in a study design that
includes PSG, lung function, inflammatory parameters,
self-reported symptoms, medication and adherence to
medication, and CPAP use would give further objective
information on this issue.
Thus, our real-life study results are important and valuable
but need to be read with caution in view of the study limita-
tions as outlined in our paper.
Compliance with ethical standard
Informed consent Informed consent was obtained from all individual
participants included in the study.
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